DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Singh H, Howie L, Bloomquist E. et al.
Abstract GS5-06: A U.S. food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy.
Cancer Res 2018;
78: GS5-06-GS05-06
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.